Nuwellis To Implement 1-for-9 Reverse Stock Split; Stock Down
(RTTNews) - Nuwellis, Inc. (NUWE), a medical device company that develops, manufactures and commercializes devices used in ultrafiltration therapy, on Friday announced that it will effect a 1-for-9 reverse split of its common stock, effective Tuesday, October 27, 2026.
The company's Aquadex FlexFlow and Aquadex SmartFlow systems are used to treat patients with fluid overload due to heart failure. The Aquadex SmartFlow system is also intended for temporary use in adult and pediatric patients.
In conjunction with the reverse stock split, the CUSIP number for the company's common stock will change to 67113Y884.
For the second quarter of 2026, the company reported revenue of approximately $2.0 million, compared with approximately $1.7 million in the prior-year quarter, representing an increase of 14%.
Net loss for the second quarter of 2026 was approximately $4.8 million, including approximately $1.7 million in non-cash warrant valuation expense associated with the June 2026 financing, compared with a net loss of $12.6 million in the prior-year quarter.
NUWE has traded between $2.52 and $1,556 over the past 52 weeks.
Currently, NUWE is trading at $4.70, down 12.48%.
Source: nasdaqtrader.com
For more such biotechstock news visit www.rttnews.com.
